Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages—the white blood ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Panelists discuss how emerging, better-tolerated oral therapies for idiopathic pulmonary fibrosis (IPF) and progressive ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

Panelists discuss recent trial data demonstrating that a novel agent not only slows lung function decline but also delays ...

Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, ...

Pliant Therapeutics has terminated its idiopathic pulmonary fibrosis (IPF) program after digging into the increased rate of ...

The University of Texas at Tyler was awarded a $219,000 grant to help fund a professor’s pulmonary fibrosis treatment project ...

B7-33 is a synthetic peptide derived from the relaxin protein family, specifically designed to interact with the relaxin ...

A new study published in the journal of Respiratory Medicine showed that a lower cumulative start rate of anti-fibrotic ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...